Executive Search Success Story: Building the Site Leadership Team for a Biopharmaceutical Company’s First In-House Sterile Fill-Finish Facility

How JRG Partners executed a confidential, multi-role North American executive search strategy that equipped a commercial-stage biopharmaceutical company with the site, aseptic manufacturing, sterility assurance, engineering and validation, and technology transfer leadership required to bring fill-finish of its biologics in-house, qualify a new isolator-based facility, and secure regulatory approval ahead of a major product launch.

The Challenge

A biopharmaceutical company had relied entirely on CDMOs for fill-finish, and capacity constraints, quality events, and the launch of a high-volume prefilled syringe product led the board to approve a $650M in-house isolator-based facility. The company had deep drug substance manufacturing expertise but had never run aseptic filling, had no sterility assurance organization, and needed to transfer six commercial products from CDMOs while qualifying the facility and preparing for a pre-approval inspection tied to the launch. Executive leadership identified several critical vulnerabilities threatening the program:

• No internal aseptic filling, sterility assurance, or isolator operations experience
• A new facility requiring commissioning, qualification, and media fills on a fixed launch timeline
• Six commercial products to transfer from CDMOs without supply interruption
• A pre-approval inspection tied to a major product launch with no tolerance for delay
• Contamination control strategy and Annex 1 compliance to be designed from the ground up
• A 400-person aseptic workforce to hire and qualify

Recognizing that the facility and launch required a site leadership team with deep fill-finish experience seated early, the Chief Technical Operations Officer and board engaged JRG Partners to recruit a Site Head & Vice President of Fill-Finish Operations, Vice President of Aseptic Manufacturing, Vice President of Sterility Assurance & Quality, Vice President of Engineering, Validation & Facilities, and Vice President of Technology Transfer & MS&T. The company required an executive search partner with deep sterile fill-finish expertise and access to leaders who had started up isolator-based facilities.

Why They Chose JRG Partners

Sterile Fill-Finish Practice Focus

JRG Partners maintains a dedicated practice recruiting sterile fill-finish leadership for biopharmaceutical and pharmaceutical manufacturers and sterile CDMOs, with deep expertise across aseptic operations, sterility assurance, isolator and barrier technology, validation, and technology transfer. This focus ensured an immediate understanding of Annex 1 requirements, contamination control strategy, and the leadership profiles that start up and qualify aseptic facilities.

Facility Start-Up Experience

Our firm has extensive experience recruiting site leadership teams for new sterile manufacturing facilities, with a clear understanding of qualification sequencing, media fill programs, and pre-approval inspection readiness.

Multi-Role Execution

Our team specializes in running coordinated site, manufacturing, quality, engineering, and technical searches in parallel, ensuring leaders are selected as a complementary unit aligned to a single start-up plan.

Our Executive Search Strategy

Phase 1 — Start-Up Plan Alignment

Our consultants partnered directly with the Chief Technical Operations Officer, head of quality, and program leadership to review facility design, qualification schedule, transfer plans, inspection timeline, and workforce requirements, defining five executive profiles sequenced to the start-up plan.

Phase 2 — Talent Identification & Mapping

Our research team performed an extensive talent mapping initiative targeting site, aseptic manufacturing, sterility assurance, engineering and validation, and technology transfer executives at biopharmaceutical and pharmaceutical manufacturers, sterile CDMOs, and aseptic operations who had led documented facility start-ups. Over 400 executives were systematically assessed across these sectors.

Phase 3 — Candidate Engagement

Priority during outreach was given to leaders with a documented history of starting up isolator-based fill-finish facilities, designing contamination control strategies compliant with Annex 1, leading commissioning, qualification, and media fill programs, transferring sterile products from CDMOs, and passing pre-approval inspections. Only candidates meeting these strict performance baselines advanced.

Phase 4 — Selection Process

Finalists presented start-up and inspection readiness plans to the Chief Technical Operations Officer and executive committee, completed structured leadership assessments, and underwent reference verification focused on quantified qualification, transfer, and regulatory outcomes.

Key Outcomes

• 400+ sterile manufacturing and quality executive profiles mapped across North America.
• Successfully placed a synchronized site leadership tier spanning site operations, aseptic manufacturing, sterility assurance, engineering and validation, and technology transfer within seven months.
• Completed qualification on schedule with all media fills passed on the first attempt.
• Transferred six commercial products from CDMOs with no supply interruption.
• Qualified a 400-person aseptic workforce before first GMP fills.
• Passed pre-approval inspection with no critical observations and launched on schedule.